 The purpose of this study is to determine the effect of short cycles of recombinant interleukin-2 also known as rIL-2 or aldesleukin given with or without anti-HIV drugs in HIV infected patients. The effects will be compared with a study group that receives no IL-2 or antiretroviral therapy. 